{"entity":{"type":"insider","cik":"0001644975","url":"/insider/0001644975","json_url":"/insider/0001644975.json","name":"Congleton Jon","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":36,"n_filings":22,"first":"2015-12-14","last":"2026-07-15","span_basis":"filed_date"},"name_variants":[{"name":"Congleton Jon","source":"filing","n_filings":22,"first_seen":"2015-12-14","last_seen":"2026-07-15"}],"transactions":[{"id":5877400,"accession":"0001933414-26-000100","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001933414-26-000100","line_url":"/filing/0001933414-26-000100#line-1","is_derivative":false,"issuer_cik":"0001644975","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001644975","owner_cik":"0001644975","owner_name":"Congleton Jon","owner_display_name":"Congleton Jon","owner_url":"/insider/0001644975","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10700.0,"shares_display":"10,700","price_per_share":27.2375,"price_display":"27.24","price_state":"stated","total_value":291441.25,"total_display":"291,441.25","total_whole":"291,441","shares_owned_after":603621.0,"shares_owned_after_display":"603,621","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-13","filed_date":"2026-07-15","scope":"insider"},{"id":5819759,"accession":"0001933414-26-000096","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001933414-26-000096","line_url":"/filing/0001933414-26-000096","is_derivative":false,"issuer_cik":"0001644975","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001644975","owner_cik":"0001644975","owner_name":"Congleton Jon","owner_display_name":"Congleton Jon","owner_url":"/insider/0001644975","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75000.0,"shares_display":"75,000","price_per_share":26.141352,"price_display":"26.14","price_state":"stated","total_value":1960601.4,"total_display":"1,960,601.40","total_whole":"1,960,601","shares_owned_after":631321.0,"shares_owned_after_display":"631,321","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-30","filed_date":"2026-06-30","scope":"insider","n_lines":2},{"id":5806873,"accession":"0001933414-26-000075","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001933414-26-000075","line_url":"/filing/0001933414-26-000075#line-1","is_derivative":false,"issuer_cik":"0001644975","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001644975","owner_cik":"0001644975","owner_name":"Congleton Jon","owner_display_name":"Congleton Jon","owner_url":"/insider/0001644975","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15730.0,"shares_display":"15,730","price_per_share":26.8264,"price_display":"26.83","price_state":"stated","total_value":421979.272,"total_display":"421,979.27","total_whole":"421,979","shares_owned_after":689321.0,"shares_owned_after_display":"689,321","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-13","filed_date":"2026-04-15","scope":"insider"},{"id":5814929,"accession":"0001644975-26-000004","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001644975-26-000004","line_url":"/filing/0001644975-26-000004","is_derivative":false,"issuer_cik":"0001644975","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001644975","owner_cik":"0001644975","owner_name":"Congleton Jon","owner_display_name":"Congleton Jon","owner_url":"/insider/0001644975","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75000.0,"shares_display":"75,000","price_per_share":26.273624162666668,"price_display":"26.27","price_state":"stated","total_value":1970521.8122,"total_display":"1,970,521.81","total_whole":"1,970,522","shares_owned_after":705504.0,"shares_owned_after_display":"705,504","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-31","filed_date":"2026-04-02","scope":"insider","n_lines":3},{"id":5827987,"accession":"0001644975-26-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001644975-26-000002","line_url":"/filing/0001644975-26-000002","is_derivative":false,"issuer_cik":"0001644975","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001644975","owner_cik":"0001644975","owner_name":"Congleton Jon","owner_display_name":"Congleton Jon","owner_url":"/insider/0001644975","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16236.0,"shares_display":"16,236","price_per_share":32.621310433604336,"price_display":"32.62","price_state":"stated","total_value":529639.5962,"total_display":"529,639.60","total_whole":"529,640","shares_owned_after":646268.0,"shares_owned_after_display":"646,268","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-13","scope":"insider","n_lines":2},{"id":4188108,"accession":"0001933414-25-000151","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001933414-25-000151","line_url":"/filing/0001933414-25-000151","is_derivative":false,"issuer_cik":"0001644975","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001644975","owner_cik":"0001644975","owner_name":"Congleton Jon","owner_display_name":"Congleton Jon","owner_url":"/insider/0001644975","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":45.442494353,"price_display":"45.44","price_state":"stated","total_value":9088498.8706,"total_display":"9,088,498.87","total_whole":"9,088,499","shares_owned_after":664155.0,"shares_owned_after_display":"664,155","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-11","filed_date":"2025-11-13","scope":"insider","n_lines":6},{"id":5135517,"accession":"0001933414-25-000129","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001933414-25-000129","line_url":"/filing/0001933414-25-000129","is_derivative":false,"issuer_cik":"0001644975","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001644975","owner_cik":"0001644975","owner_name":"Congleton Jon","owner_display_name":"Congleton Jon","owner_url":"/insider/0001644975","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15100.0,"shares_display":"15,100","price_per_share":42.67065369536424,"price_display":"42.67","price_state":"stated","total_value":644326.8708,"total_display":"644,326.87","total_whole":"644,327","shares_owned_after":832857.0,"shares_owned_after_display":"832,857","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-13","filed_date":"2025-10-15","scope":"insider","n_lines":2},{"id":4039089,"accession":"0001933414-25-000078","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001933414-25-000078","line_url":"/filing/0001933414-25-000078#line-1","is_derivative":false,"issuer_cik":"0001644975","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001644975","owner_cik":"0001644975","owner_name":"Congleton Jon","owner_display_name":"Congleton Jon","owner_url":"/insider/0001644975","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15884.0,"shares_display":"15,884","price_per_share":14.5071,"price_display":"14.51","price_state":"stated","total_value":230430.7764,"total_display":"230,430.78","total_whole":"230,431","shares_owned_after":846405.0,"shares_owned_after_display":"846,405","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-11","filed_date":"2025-07-15","scope":"insider"},{"id":4324326,"accession":"0001933414-25-000044","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001933414-25-000044","line_url":"/filing/0001933414-25-000044#line-1","is_derivative":false,"issuer_cik":"0001644975","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001644975","owner_cik":"0001644975","owner_name":"Congleton Jon","owner_display_name":"Congleton Jon","owner_url":"/insider/0001644975","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15319.0,"shares_display":"15,319","price_per_share":12.1942,"price_display":"12.19","price_state":"stated","total_value":186802.9498,"total_display":"186,802.95","total_whole":"186,803","shares_owned_after":862289.0,"shares_owned_after_display":"862,289","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-11","filed_date":"2025-04-15","scope":"insider"},{"id":4215529,"accession":"0001933414-25-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001933414-25-000003","line_url":"/filing/0001933414-25-000003#line-1","is_derivative":false,"issuer_cik":"0001644975","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001644975","owner_cik":"0001644975","owner_name":"Congleton Jon","owner_display_name":"Congleton Jon","owner_url":"/insider/0001644975","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18333.0,"shares_display":"18,333","price_per_share":9.0592,"price_display":"9.06","price_state":"stated","total_value":166082.3136,"total_display":"166,082.31","total_whole":"166,082","shares_owned_after":877608.0,"shares_owned_after_display":"877,608","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-13","filed_date":"2025-01-15","scope":"insider"},{"id":2134891,"accession":"0001933414-24-000045","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001933414-24-000045","line_url":"/filing/0001933414-24-000045#line-1","is_derivative":false,"issuer_cik":"0001644975","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001644975","owner_cik":"0001644975","owner_name":"Congleton Jon","owner_display_name":"Congleton Jon","owner_url":"/insider/0001644975","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15271.0,"shares_display":"15,271","price_per_share":13.518,"price_display":"13.52","price_state":"stated","total_value":206433.378,"total_display":"206,433.38","total_whole":"206,433","shares_owned_after":895941.0,"shares_owned_after_display":"895,941","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-11","filed_date":"2024-10-15","scope":"insider"},{"id":2408721,"accession":"0001933414-24-000033","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001933414-24-000033","line_url":"/filing/0001933414-24-000033#line-1","is_derivative":false,"issuer_cik":"0001644975","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001644975","owner_cik":"0001644975","owner_name":"Congleton Jon","owner_display_name":"Congleton Jon","owner_url":"/insider/0001644975","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15746.0,"shares_display":"15,746","price_per_share":13.3415,"price_display":"13.34","price_state":"stated","total_value":210075.259,"total_display":"210,075.26","total_whole":"210,075","shares_owned_after":911212.0,"shares_owned_after_display":"911,212","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-11","filed_date":"2024-07-12","scope":"insider"},{"id":3103185,"accession":"0001933414-24-000032","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001933414-24-000032","line_url":"/filing/0001933414-24-000032#line-3","is_derivative":false,"issuer_cik":"0001644975","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001644975","owner_cik":"0001644975","owner_name":"Congleton Jon","owner_display_name":"Congleton Jon","owner_url":"/insider/0001644975","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14940.0,"shares_display":"14,940","price_per_share":11.7294,"price_display":"11.73","price_state":"stated","total_value":175237.236,"total_display":"175,237.24","total_whole":"175,237","shares_owned_after":926958.0,"shares_owned_after_display":"926,958","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-20","filed_date":"2024-06-20","scope":"insider"},{"id":3103183,"accession":"0001933414-24-000032","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001933414-24-000032","line_url":"/filing/0001933414-24-000032#line-2","is_derivative":false,"issuer_cik":"0001644975","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001644975","owner_cik":"0001644975","owner_name":"Congleton Jon","owner_display_name":"Congleton Jon","owner_url":"/insider/0001644975","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16607.0,"shares_display":"16,607","price_per_share":11.9873,"price_display":"11.99","price_state":"stated","total_value":199073.0911,"total_display":"199,073.09","total_whole":"199,073","shares_owned_after":941898.0,"shares_owned_after_display":"941,898","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-18","filed_date":"2024-06-20","scope":"insider"},{"id":3103177,"accession":"0001933414-24-000032","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001933414-24-000032","line_url":"/filing/0001933414-24-000032#line-1","is_derivative":false,"issuer_cik":"0001644975","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001644975","owner_cik":"0001644975","owner_name":"Congleton Jon","owner_display_name":"Congleton Jon","owner_url":"/insider/0001644975","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17766.0,"shares_display":"17,766","price_per_share":12.2544,"price_display":"12.25","price_state":"stated","total_value":217711.6704,"total_display":"217,711.67","total_whole":"217,712","shares_owned_after":958505.0,"shares_owned_after_display":"958,505","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-17","filed_date":"2024-06-20","scope":"insider"},{"id":2574631,"accession":"0001933414-24-000029","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001933414-24-000029","line_url":"/filing/0001933414-24-000029#line-3","is_derivative":false,"issuer_cik":"0001644975","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001644975","owner_cik":"0001644975","owner_name":"Congleton Jon","owner_display_name":"Congleton Jon","owner_url":"/insider/0001644975","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16229.0,"shares_display":"16,229","price_per_share":12.5185,"price_display":"12.52","price_state":"stated","total_value":203162.7365,"total_display":"203,162.74","total_whole":"203,163","shares_owned_after":976271.0,"shares_owned_after_display":"976,271","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-14","filed_date":"2024-06-14","scope":"insider"},{"id":2574626,"accession":"0001933414-24-000029","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001933414-24-000029","line_url":"/filing/0001933414-24-000029#line-2","is_derivative":false,"issuer_cik":"0001644975","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001644975","owner_cik":"0001644975","owner_name":"Congleton Jon","owner_display_name":"Congleton Jon","owner_url":"/insider/0001644975","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39961.0,"shares_display":"39,961","price_per_share":12.7381,"price_display":"12.74","price_state":"stated","total_value":509027.2141,"total_display":"509,027.21","total_whole":"509,027","shares_owned_after":992500.0,"shares_owned_after_display":"992,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-13","filed_date":"2024-06-14","scope":"insider"},{"id":2574622,"accession":"0001933414-24-000029","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001933414-24-000029","line_url":"/filing/0001933414-24-000029#line-1","is_derivative":false,"issuer_cik":"0001644975","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001644975","owner_cik":"0001644975","owner_name":"Congleton Jon","owner_display_name":"Congleton Jon","owner_url":"/insider/0001644975","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16607.0,"shares_display":"16,607","price_per_share":12.7665,"price_display":"12.77","price_state":"stated","total_value":212013.2655,"total_display":"212,013.27","total_whole":"212,013","shares_owned_after":1032461.0,"shares_owned_after_display":"1,032,461","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-12","filed_date":"2024-06-14","scope":"insider"},{"id":8758652,"accession":"0001933414-23-000093","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001933414-23-000093","line_url":"/filing/0001933414-23-000093#line-1","is_derivative":false,"issuer_cik":"0001644975","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001644975","owner_cik":"0001644975","owner_name":"Congleton Jon","owner_display_name":"Congleton Jon","owner_url":"/insider/0001644975","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4250.0,"shares_display":"4,250","price_per_share":5.9661,"price_display":"5.97","price_state":"stated","total_value":25355.925,"total_display":"25,355.92","total_whole":"25,356","shares_owned_after":1049068.0,"shares_owned_after_display":"1,049,068","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-22","filed_date":"2023-11-27","scope":"insider"},{"id":8347118,"accession":"0001933414-23-000067","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001933414-23-000067","line_url":"/filing/0001933414-23-000067#line-1","is_derivative":false,"issuer_cik":"0001644975","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001644975","owner_cik":"0001644975","owner_name":"Congleton Jon","owner_display_name":"Congleton Jon","owner_url":"/insider/0001644975","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2250.0,"shares_display":"2,250","price_per_share":12.08,"price_display":"12.08","price_state":"stated","total_value":27180.0,"total_display":"27,180.00","total_whole":"27,180","shares_owned_after":1044818.0,"shares_owned_after_display":"1,044,818","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-06","filed_date":"2023-09-08","scope":"insider"},{"id":8666833,"accession":"0001933414-23-000065","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001933414-23-000065","line_url":"/filing/0001933414-23-000065#line-1","is_derivative":false,"issuer_cik":"0001644975","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001644975","owner_cik":"0001644975","owner_name":"Congleton Jon","owner_display_name":"Congleton Jon","owner_url":"/insider/0001644975","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2250.0,"shares_display":"2,250","price_per_share":12.1,"price_display":"12.10","price_state":"stated","total_value":27225.0,"total_display":"27,225.00","total_whole":"27,225","shares_owned_after":1042568.0,"shares_owned_after_display":"1,042,568","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-17","filed_date":"2023-08-21","scope":"insider"},{"id":8458948,"accession":"0001933414-23-000061","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001933414-23-000061","line_url":"/filing/0001933414-23-000061#line-1","is_derivative":false,"issuer_cik":"0001644975","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001644975","owner_cik":"0001644975","owner_name":"Congleton Jon","owner_display_name":"Congleton Jon","owner_url":"/insider/0001644975","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":12.89,"price_display":"12.89","price_state":"stated","total_value":25780.0,"total_display":"25,780.00","total_whole":"25,780","shares_owned_after":1040318.0,"shares_owned_after_display":"1,040,318","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-11","filed_date":"2023-08-11","scope":"insider"},{"id":3036737,"accession":"0001104659-16-127973","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-16-127973","line_url":"/filing/0001104659-16-127973#line-1","is_derivative":false,"issuer_cik":"0001626199","issuer_name":"Nivalis Therapeutics, Inc.","issuer_ticker":"NVLS","issuer_name_source":null,"issuer_url":"/issuer/0001626199","owner_cik":"0001644975","owner_name":"Congleton Jon","owner_display_name":"Congleton Jon","owner_url":"/insider/0001644975","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":3.8689,"price_display":"3.87","price_state":"stated","total_value":19344.5,"total_display":"19,344.50","total_whole":"19,345","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-16","filed_date":"2016-06-17","scope":"insider"},{"id":2906470,"accession":"0001104659-16-107576","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-16-107576","line_url":"/filing/0001104659-16-107576#line-1","is_derivative":false,"issuer_cik":"0001626199","issuer_name":"Nivalis Therapeutics, Inc.","issuer_ticker":"NVLS","issuer_name_source":null,"issuer_url":"/issuer/0001626199","owner_cik":"0001644975","owner_name":"Congleton Jon","owner_display_name":"Congleton Jon","owner_url":"/insider/0001644975","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":4.2169,"price_display":"4.22","price_state":"stated","total_value":21084.5,"total_display":"21,084.50","total_whole":"21,085","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-24","filed_date":"2016-03-25","scope":"insider"},{"id":3206750,"accession":"0001104659-16-107167","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-16-107167","line_url":"/filing/0001104659-16-107167#line-1","is_derivative":false,"issuer_cik":"0001626199","issuer_name":"Nivalis Therapeutics, Inc.","issuer_ticker":"NVLS","issuer_name_source":null,"issuer_url":"/issuer/0001626199","owner_cik":"0001644975","owner_name":"Congleton Jon","owner_display_name":"Congleton Jon","owner_url":"/insider/0001644975","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":4.3815,"price_display":"4.38","price_state":"stated","total_value":21907.5,"total_display":"21,907.50","total_whole":"21,908","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-22","filed_date":"2016-03-23","scope":"insider"},{"id":8319597,"accession":"0001104659-15-084577","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-15-084577","line_url":"/filing/0001104659-15-084577#line-1","is_derivative":false,"issuer_cik":"0001626199","issuer_name":"Nivalis Therapeutics, Inc.","issuer_ticker":"NVLS","issuer_name_source":null,"issuer_url":"/issuer/0001626199","owner_cik":"0001644975","owner_name":"Congleton Jon","owner_display_name":"Congleton Jon","owner_url":"/insider/0001644975","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":8.1,"price_display":"8.10","price_state":"stated","total_value":40500.0,"total_display":"40,500.00","total_whole":"40,500","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-11","filed_date":"2015-12-14","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":36,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":8,"open_market":true},{"code":"S","label":"Open-market sale","n":28,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":36},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001933414","name":"Mineralys Therapeutics, Inc.","url":"/issuer/0001933414","role":"Director, Officer (Chief Executive Officer)","n_filings":18,"first_seen":"2023-08-11","last_seen":"2026-07-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001626199","name":"Nivalis Therapeutics, Inc.","url":"/issuer/0001626199","role":"Director, Officer (President and CEO)","n_filings":4,"first_seen":"2015-12-14","last_seen":"2016-06-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001644975","retrieved_at":"2026-08-23T04:45:05+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}